Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide

被引:158
作者
AlonsoGalicia, M
Drummond, HA
Reddy, KK
Falck, JR
Roman, RJ
机构
[1] MED COLL WISCONSIN,DEPT PHYSIOL,MILWAUKEE,WI 53226
[2] UNIV TEXAS,SW MED CTR,DEPT MOL GENET,DALLAS,TX 75235
关键词
nitric oxide; vasculature; enzymes;
D O I
10.1161/01.HYP.29.1.320
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Nitric oxide (NO) inhibits a variety of heme-containing enzymes, including NO synthase and cytochrome P4501A1 and 2B1. The present study examined whether NO inhibits the production of 20-hydroxyeicosatetraenoic acid (20-HETE) by cytochrome P4504A enzymes and whether blockade of the production of this substance contributes to the vascular effects of NO. Sodium nitroprusside (SNP; 10(-5), 10(-4), and 10(-3) mol/L) reduced the production of 20-HETE by renal microsomes incubated with arachidonic acid to 71 +/- 5%, 29 +/- 4%, and 4 +/- 2% of control, respectively (n = 5). Similar results were obtained with the use of 1-propanamine, 3-(2-hydroxy-2-nitroso-1-propylhydrazino) (n = 3). To determine whether inhibition of 20-HETE contributes to the vasodilatory effects of NO, the effects of dibromo-dodecenyl-methylsulfimide (DDMS), a selective inhibitor of the formation of 20-HETE, on the response to SNP (10(-7) to 10(-3) mol/L) were examined in rat renal arterioles preconstricted with phenylephrine (n = 5). SNP increased vascular diameter in a concentration-dependent manner to 82 +/- 4% of control. After DDMS (25 mu mol/L), SNP (10(-3) mol/L) increased vascular diameter by only 17 +/- 3%. The effects of DDMS on the mean arterial pressure (MAP) and renal blood flow (RBF) responses to infusion of an NO donor and a synthase inhibitor were also examined in thiobutabarbital-anesthetized, Sprague-Dawley rats. infusion of MAHMA NONOate at 1, 3, 5, and 10 nmol/min reduced MAP by 16 +/- 2, 30 +/- 3, 40 +/- 5, and 48 +/- 5 mm Hg and lowered renal vascular resistance (RVR) by 15 +/- 3%, 26 +/- 2%, 30 +/- 3%, and 34 +/- 4% of control. After DDMS (10 mg/kg, n = 7 rats), the MAP and RVR responses to 1-hexamine, 6-(2-hydroxy-1-methyl-2-nitrohydrazino)N-methyl (MAHMA NONOate) averaged only 20% of those seen during control. In other experiments, MAP increased by 32 +/- 4% and RBF fell to 56 +/- 5% of control after administration of N-nitro-L-arginine (L-NArg) (10 mg/kg IV). After DDMS (10 mg/kg, n = 7 rats), MAP increased by only 19 +/- 4% and RBF fell by only 7 +/- 4% after L-NArg. These results indicate that NO inhibits cytochrome P4504A enzymes and that inhibition of the production of 20-HETE contributes to the vasodilatory effects of NO.
引用
收藏
页码:320 / 325
页数:6
相关论文
共 23 条
[1]   NITRIC-OXIDE IN THE KIDNEY - SYNTHESIS, LOCALIZATION, AND FUNCTION [J].
BACHMANN, S ;
MUNDEL, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (01) :112-129
[2]   NITRIC-OXIDE DIRECTLY ACTIVATES CALCIUM-DEPENDENT POTASSIUM CHANNELS IN VASCULAR SMOOTH-MUSCLE [J].
BOLOTINA, VM ;
NAJIBI, S ;
PALACINO, JJ ;
PAGANO, PJ ;
COHEN, RA .
NATURE, 1994, 368 (6474) :850-853
[3]  
BRANDSCHIEBER E, 1996, HYPERTENSION, V28, P542
[4]   THE ROLE OF NITRIC-OXIDE AND OTHER ENDOTHELIUM-DERIVED VASOACTIVE SUBSTANCES IN VASCULAR-DISEASE [J].
COHEN, RA .
PROGRESS IN CARDIOVASCULAR DISEASES, 1995, 38 (02) :105-128
[5]   ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION - BEYOND NITRIC-OXIDE AND CYCLIC-GMP [J].
COHEN, RA ;
VANHOUTTE, PM .
CIRCULATION, 1995, 92 (11) :3337-3349
[6]  
DUTHU GS, 1979, DRUG METAB DISPOS, V7, P263
[7]  
Griscavage J M, 1995, Adv Pharmacol, V34, P215
[8]   ROLE OF CYTOCHROME-P-450 ENZYMES AND METABOLITES OF ARACHIDONIC-ACID IN THE CONTROL OF VASCULAR TONE [J].
HARDER, DR ;
CAMPBELL, WB ;
ROMAN, RJ .
JOURNAL OF VASCULAR RESEARCH, 1995, 32 (02) :79-92
[9]  
HARDER DR, 1994, AM J PHYSIOL, V266, pH1840
[10]   NITRIC-OXIDE COMPLEXES OF INDUCIBLE NITRIC-OXIDE SYNTHASE - SPECTRAL CHARACTERIZATION AND EFFECT ON CATALYTIC ACTIVITY [J].
HURSHMAN, AR ;
MARLETTA, MA .
BIOCHEMISTRY, 1995, 34 (16) :5627-5634